Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vector Later-Stage Equity Funds
Deerfield, Illinois, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Vector Later-Stage Equity Funds is a private equity and venture capital firm that specialized in late-stage investments within the life sciences and healthcare industries. The firm focused on providing capital to biotechnology and medical technology companies with established clinical data or commercial products. Managed by industry veterans such as James L. Foght, Ph.D., the fund leveraged deep sector expertise to support the growth and development of its portfolio companies. It was notably involved in financing rounds for companies like Orchestra Therapeutics and The Immune Response Corporation during the late 1990s and early 2000s.
- Industry
- Investors
Beyond the preview
Go deeper on Vector Later-Stage Equity Funds.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vector Later-Stage Equity Funds.